fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Sharon Bio-Medicine Ltd

Sharon Bio-Medicine Ltd

Updated on July 6, 2020

Stock/Share Code - SHARONBIO

Sharon Bio-Medicine Limited is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and commercialization of pharmaceutical products. The Company operates in three segments, which include Active Pharma Ingredients (API's), Formulations and Toxicology.

Below is the details of SHARONBIO Sharon Bio-Medicine Ltd

Market Cap₹39.25 Cr.
Current Price ₹8.75 as on 13 Sep 17
52 Week High / Low Price /
Face Value₹2
Stock P/E2.69
Book Value-₹54.43
Dividend Yield0.00 %
ROCE-18.03 %
ROE-675 %
Sales Growth (3yrs)-31.40 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Formulations
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros:
Cons: The company has delivered a poor growth of -12.58% over past five years. Promoter holding is low: 32.53% Company has a low return on equity of -25.34% for last 3 years. Company has high debtors of 263.80 days.

Sharon Bio-Medicine Ltd Price Chart

Sharon Bio-Medicine Ltd Price Chart

Sharon Bio-Medicine Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Ajanta Pharma ₹1,420.35 28.27 ₹13,298.18 Cr. 0.85 ₹129.16 Cr. 47.33 32.38 681.96 23.85
2. ERIS Lifescience ₹447.7 23.06 ₹6,788.35 Cr. 0.57 ₹63.47 Cr. -20.80 5.55 266.40 26.43
3. Caplin Point Lab ₹344.25 11.23 ₹2,422.08 Cr. 0.69 ₹58.56 Cr. 27.78 43.50 228.21 48.53
4. Amrutanjan Healt ₹369.05 31.55 ₹992.67 Cr. 0.63 ₹9.49 Cr. 79.40 18.32 82.75 25.42
5. Hester Bios ₹1,230.4 26.73 ₹968.55 Cr. 0.97 ₹11.52 Cr. -10.00 10.85 50.69 26.65
6. Bliss GVS Pharma ₹105.35 9.06 ₹966.05 Cr. 1.07 ₹23.75 Cr. -8.09 -32.93 147.85 26.90
7. Lincoln Pharma. ₹161.9 5.93 ₹302.2 Cr. 0.99 ₹10.91 Cr. 19.23 16.69 98.52 22.58
8. Sharon Bio-Med. 2.69 ₹39.25 Cr. 0.00 ₹1.59 Cr. 156.25 23.01 39.29 -18.03

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Sharon Bio-Medicine Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019
Sales -212231403533393240444239
YOY Sales Growth %-41.99%-43.48%-31.59%19.14%68.82%53.52%25.57%-21.06%14.56%32.11%7.27%23.01%
Expenses -272428373627342834373634
Material Cost %86.17%51.17%44.89%51.19%53.93%41.36%50.40%44.30%47.84%49.51%48.83%49.20%
Employee Cost %27.71%26.16%18.14%14.83%15.07%17.79%16.53%19.69%17.52%15.80%18.24%19.47%
Operating Profit-6-234-16546765
OPM %-31%-10%11%9%-2%19%12%12%15%16%15%13%
Other Income6-9000-411-11-6111
Interest900000000000
Depreciation133323333224
Profit before tax-11-9601-743-04-5652
Tax %53%-0%0%0%-0%0%0%-0%0%-0%0%0%
Net Profit-5-9601-743-04-5652
EPS in Rs-0.43-8.040.030.05-0.530.370.270.000.32-2.320.390.13
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016TTM
Sales -891713354204966067851,0601,314834253166
Sales Growth %92%96%25%18%22%30%35%24%-37%-81%
Expenses -751452963814455356909391,157868387141
Material Cost %80%81%85%87%84%83%84%85%85%97%131%
Manufacturing Cost %2%2%1%1%1%1%1%1%1%3%7%
Employee Cost %2%1%1%1%2%2%2%1%1%2%7%
Other Cost %1%1%1%2%2%1%1%1%1%2%8%
Operating Profit14263939527195120157-34-13424
OPM %16%15%12%9%10%12%12%11%12%-4%-53%15%
Other Income0122-01112-74-69-59
Interest12714212734435994710
Depreciation11446891215191512
Profit before tax132331222436536685-221-289-46
Tax %16%22%13%16%22%15%22%20%18%-2%-3%
Net Profit111827191931425370-226-299-46
EPS in Rs1.051.722.561.741.752.923.945.016.590.000.00-1.48
Dividend Payout %9%9%5%7%8%6%5%3%5%-0%-0%

Compounded Sales Growth

  • 5 Years:: -12.58%
  • 3 Years:: -31.40%
  • TTM:: 18.65%

Compounded Profit Growth

  • TTM:: 81.49%

Return on Equity

  • 10 Years:: -12.30%
  • 5 Years:: -26.75%
  • 3 Years:: -18.52%
  • 1 Year:: 0.00%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016Sep 2019
Share Capital -101011111111111121242424
Equity Capital10.0310.1810.5610.5610.5610.5610.5610.5621.1123.7923.79
Reserves1333708810413312817924281-219-671
Borrowings1665214262343344508644725824836827
Other Liabilities -143634374398128139173838285
Trade Payables5.5121.5819.8722.6526.3132.3649.6759.8661.1751.2740.0346.23
Other liability items8.7913.9314.6214.1417.0266.0678.6579.00111.7031.4841.7039.11
Total Liabilities541453303975015867749721,1621,012723265
Fixed Assets -9455256184181201272325332319150
Gross Block11485967201206236318381407408
Accumulated Depreciation2371117263446567590
CWIP1015441072327604315000
Investments004144441100
Other Assets -3584229233290374509654820678404115
Inventories14.9326.2757.7589.66116.67155.21196.22260.24322.45301.42179.9934.27
Trade receivables16.3754.2794.94133.46158.77192.54260.12355.10414.31315.02183.1823.41
Cash Equivalents0.390.4372.623.352.393.846.286.2712.2716.0110.1625.98
Loans n Advances3.292.913.556.4712.3822.5946.2031.9863.3136.4121.771.28
Other asset items0.150.120.080.040.010.000.00-0.018.119.529.1229.89
Total Assets541453303975015867749721,1621,012723265

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016
Cash from Operating Activity --5-14-40-50-28-36-53-70-69-82-28
Profit from operations14193536466686108144-113-214
Receivables-12-38-41-41-31-34-68-95-5999132
Inventory-7-11-31-32-27-39-41-64-6221121
Payables216425719101-7-11
Loans Advances00000-11-2414-392515
Interest paid-10-7-14-210-34-43-59-94-71
Direct taxes-20000000000
Other operating items00000-279-14-15-0
Cash from Investing Activity --11-43-41-66-51-8-61-64-27-100
Fixed assets purchased-10.74-42.88-39.34-70.99-49.89-9.61-62.07-65.17-31.81-10.89-1.47
Investments purchased0.00-0.15-4.260.00-3.060.00-0.100.000.000.000.00
Investments sold0.000.000.003.120.220.250.000.002.750.200.97
Interest received0.000.512.511.831.571.120.930.891.680.630.64
Cash from Financing Activity -16571544778461171341039622
Proceeds from shares0.004.5011.240.360.000.000.000.000.0066.830.00
Proceeds from borrowings8.9749.01149.0151.0780.1545.650.000.00117.230.000.00
Repayment of borrowings0.000.000.00-3.110.00-44.590.000.00-35.730.000.00
Dividends paid-1.00-1.53-1.27-1.27-1.58-1.90-1.90-1.58-3.800.000.00
Share application money8.015.000.000.000.0046.740.000.000.000.000.00
Application money refund0.000.00-5.000.000.000.000.000.000.000.000.00
Other financing items-0.21-0.26-0.21-0.21-0.27-0.21118.56136.0825.1528.8722.22
Net Cash Flow0072-69-112-064-6

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Jun 2006Jun 2007Jun 2008Jun 2009Jun 2010Jun 2011Jun 2012Jun 2013Jun 2014Jun 2015Mar 2016
ROCE %34%19%11%11%13%15%15%16%-5%-18%
Debtor Days67116104116117116121122115138264
Inventory Turnover8.307.975.704.814.464.474.644.512.671.01

Announcements & News

Recent Announcements

Credit Ratings

Annual Reports

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Sharon Bio-Medicine Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.